Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06767384

Diagnostic Accuracy of x Ray Kub in Diagnosing Renal Calculi Keeping CT Scan as Gold Standard

In clinical practice both Xray and CT Scan KUB are reliable,however, Ctscan is superior to X ray KUB in detecting renal and ureteric calculi,the reson being stone that are missed by xray KUB are usually small and sould pass spontenously while other are usually with improper bowel preparation

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female who will be advised X ray KUB and CT scan KUB for suspected renal & uretrric calculi(flank pain )for <24 hours .
  • Age 18-49 years (because this is common age group for renal &ureteric calculi).

Exclusion criteria

  • Female patients with pregnancy.
  • Morbidly obese patients (Men>129 kg women>113kg)
  • Patients with history of any abdominal trauma

Treatment and study plan

X-Ray

Radiation

To determine diagnostic accuracy of x-ray KUB in diagnostic renal and ureter calculi keeping CT scan KUB as a gold standard.

Primary outcomes

  1. multidetector computed tomography

    Time frame: 12 Months

    multidetector computed tomography scan Kidney UreterBladder

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Jan 9, 2025
Registry last updated
Jan 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.